Atlas Trials

Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma

Clinical trial NCT00561301 · UNKNOWN

Trial details

NCT number
NCT00561301
Sponsor
Cooperative Study Group A for Hematology
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2006-11-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.